Editor’s Note: This blog post originally appeared on Sheridan Healthcare’s website.
An alarming new study from the Harvard T.H. Chan School of Public Health and the Broad Institute of MIT and Harvard suggests that carbapenem-resistant Enterobacteriaceae (CRE)—a new class of superbug referred to as “nightmare bacteria” by former CDC director Dr. Tom Frieden—may be spreading more widely and more stealthily than was previously thought. The researchers found that CREs are growing in numbers and strength, are far more diverse than expected, and have many more mechanisms for not only resisting antibiotics but also spreading that resistance to other bacteria than have been identified to date. The study’s findings were published in January in the Proceedings of the National Academy of Sciences (PNAS). Click here to continue>>
News From Our Partners
